Evaluation of anxiety in individuals with end-stage lung disease during covid-19 pandemic

Abstract

INTRODUCTION: With this study, it was aimed to determine the anxiety levels of individuals with end-stage lung disease during the COVID-19 outbreak. METHODS: Adults with respiratory failure due to underlying lung disease and using long-term oxygen therapy were included in the study. State and trait anxiety levels of the participants were determined according to the STAI-1 and STAI-2 scores. RESULTS: According to the STAI-1 evaluation, 64 (28,57) of the cases had mild, 142 (63,39) moderate, and 18 (8,03) severe anxiety, and according to the STAI-2 evaluation, 44 (19,64) had mild, 164 (73,21) moderate, and 16 (7.14) had severe anxiety. According to the STAI-2 evaluation, the anxiety level was statistically significantly higher in women (median; min-max: 50; 38-67) compared to men (42; 26-75) (p <0.001). Both STAI-1 and STAI-2 scores were higher in patients with psychiatric disease (52.5; 42-61 and 52.5; 43-66, respectively) than those without psychiatric disease (47; 21-67 and 43; 26-75, respectively) (p = 0.015 and p = 0.002, respectively). STAI-2 scores were higher in individuals who haven't contracted COVID-19 (44; 34-75) than those who did (40; 34-75) (p <0.001). STAI-1 and STAI-2 scores were higher in participants who think that social measures taken against the epidemic are sufficient (50.5; 30-67 and 45.5; 34-75, respectively) compared to those who think insufficient (45; 21-60 and 43; 26-62, respectively) (p <0.001 and p = 0.008, respectively). DISCUSSION AND CONCLUSION: Anxiety is observed in individuals with a diagnosis of end-stage lung disease.

Keywords

• anxiety
• covid-19
• pandemic
• respiratory failure
• sars-cov-2.